BIOMAT Database Logo BIOMAT Database Logo

Erythropoietin upregulates angiotensin receptors in cultured rat vascular smooth muscle cells. 1998

J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Veterans Administration Greater Los Angeles Health Care System, Sepulveda, California 91343, USA.

OBJECTIVE Plasma renin is not elevated in recombinant human erythropoietin (rhEPO)-induced hypertension but angiotensin converting enzyme inhibitors reduce blood pressure in both human and animal studies. Since rhEPO elevates renin and angiotensinogen messenger RNAs in angiotensin II target tissues such as the aorta, we explored the actions of rhEPO on renin-angiotensin system-related gene transcription of cultured rat vascular smooth muscle cells. METHODS To separate direct actions of rhEPO from those mediated secondarily by potential activation of the renin-angiotensin system, vascular smooth muscle cells were cultured with rhEPO and enalapril to inhibit the angiotensin converting enzyme and losartan to inhibit angiotensin II type 1 receptors. RESULTS Vascular smooth muscle cells cultured with rhEPO (6-8 units/ml) demonstrated elevations (40-120%) in messenger RNAs of the renin-angiotensin system (renin, angiotensinogen, angiotensin receptor types 1 and 2) and increased levels of several messenger RNAs known to respond to angiotensin II (transforming growth factor-beta, insulin-like growth factor-II, epidermal growth factor, c-fos and platelet-derived growth factor). In contrast, cells cultured in the presence of rhEPO and enalapril or losartan showed elevations of messenger RNA for only the two types of angiotensin II receptor. This increase was higher than that obtained when cells were cultured with rhEPO or either antagonist alone. The increase in specific binding of angiotensin II to cells cultured in the presence of rhEPO and enalapril or rhEPO and losartan paralleled the changes in receptor messenger RNA. CONCLUSIONS rhEPO exerts its primary action on vascular smooth muscle cells via an increase in angiotensin receptor messenger RNA, resulting in a parallel increase in angiotensin II receptor expression. We suggest that increased receptor expression secondarily mediates the expression of other renin-angiotensin system messenger RNAs, which leads to angiotensin II-responsive gene transcription. The elevation in angiotensin II receptors, as observed in response to rhEPO, may provide a mechanism by which other forms of renin-dependent hypertension are initiated.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001013 Aorta, Thoracic The portion of the descending aorta proceeding from the arch of the aorta and extending to the DIAPHRAGM, eventually connecting to the ABDOMINAL AORTA. Aorta, Ascending,Aorta, Descending,Aortic Arch,Aortic Root,Arch of the Aorta,Descending Aorta,Sinotubular Junction,Ascending Aorta,Thoracic Aorta,Aortic Roots,Arch, Aortic,Ascending Aortas,Junction, Sinotubular,Root, Aortic,Sinotubular Junctions
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Functional angiotensin II receptors in cultured vascular smooth muscle cells.
February 1982, The Journal of cell biology,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Angiotensin receptors in cultured rat aortic smooth muscle (A-10) cells.
January 1990, Proceedings of the Western Pharmacology Society,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Erythropoietin modulates angiotensin II- or noradrenaline-induced Ca(2+) mobilization in cultured rat vascular smooth-muscle cells.
March 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
April 2003, Circulation,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells.
March 1994, FEBS letters,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells.
December 2000, Biochemical and biophysical research communications,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Angiotensin-receptor signaling in cultured vascular smooth muscle cells.
May 1986, The American journal of physiology,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells.
August 1999, The American journal of physiology,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells.
January 1991, The American journal of physiology,
J D Barrett, and Z Zhang, and J H Zhu, and D B Lee, and H J Ward, and N Jamgotchian, and M S Hu, and A Fredal, and M Giordani, and P Eggena
Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells.
November 2000, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!